RepliCel Presents Its Technology Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference February 18, 2021
Healthcare Roundup – Sesen price target raised on prospects for bladder cancer therapy; Sundial makes $22M investment in cannabis edibles company Indiva February 16, 2021Life Science
Healthcare Roundup – G1 Therapeutics jumps 16.9% as trilaciclib wins FDA approval; Bionano Genomics shares hit all-time high, spiking nearly 23% February 12, 2021Life Science
Healthcare Roundup – Generex announces receipt of $2M for its COVID-19 vaccine development; I-Mab’s cancer therapy greenlighted in China for phase 1 trial February 10, 2021Life Science
Healthcare Roundup – Omega Health buys 24 facilities for $510M; Align Tech up 13% as analysts view Q4 2020 results favorably February 4, 2021Life Science
Healthcare Roundup – Jazz to acquire GW Pharma in cash-and-stock deal valued at $7.2B; Anavex gains after favorable data from Cassava Sciences in Alzheimer’s February 4, 2021Life Science
Healthcare Roundup – AstraZeneca gets European nod for COVID-19 vaccine; eHealth announces $225M strategic investment from H.I.G. capital January 30, 2021Life Science
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement January 25, 2021Life Science
Healthcare Roundup – Intuitive Surgical earns mixed reviews from analysts despite earnings beat; Amyris acquires Terasana Brand for offering clean cannabinoid consumer products January 22, 2021Life Science
Healthcare Roundup – Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan; Gene editors raise equity as shares climb amid investor interest January 21, 2021Life Science
Healthcare Roundup – COVID-19 Jabs: Israel trades data for doses; U.K. to vaccinate all adults by September；Grifols to trial new immunoglobulin therapy against COVID-19 January 18, 2021Life Science
Healthcare Roundup – Norway says deaths after COVID-19 jab may be from side effects, Sorrento could nearly quadruple in value: analyst January 15, 2021Life Science
Healthcare Roundup – JNJ’s single-dose COVID-19 vaccine viewed favorably by analysts; Eli Lilly up 20% after donanemab shows clinical benefit in mid-stage Alzheimer’s study January 12, 2021Life Science
Replicel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis December 22, 2020Life Science
